New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
16:10 EDTRCPTReceptos files to sell common stock, no amount given
Receptos intends to use the net proceeds received from this offering to fund continued development of its product candidate RPC1063 in ongoing clinical trials for relapsing multiple sclerosis and ulcerative colitis, development of its in-licensed product candidate RPC4046 in a clinical trial for eosinophilic esophagitis, other ongoing preclinical and research programs and for general corporate purposes including working capital. International, Inc. are acting as co-managers. Credit Suisse Securities, Leerink Partners LLC and BMO Capital Markets Corp. are acting as joint book-running managers for the offering. Wedbush PacGrow Life Sciences and Nomura Securities
News For RCPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2015
07:31 EDTRCPTCelgene commences tender offer for Receptos
Subscribe for More Information
July 27, 2015
10:40 EDTRCPTIsis 'most obvious' Biogen takeover target, TheStreet's Feuerstein says
Subscribe for More Information
July 21, 2015
10:24 EDTRCPTOptions with decreasing implied volatility
Subscribe for More Information
06:29 EDTRCPTCelgene price target raised to $160 from $147 at Piper Jaffray
Subscribe for More Information
06:24 EDTRCPTPiper expects 'stronger, bolder' move from Biogen
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use